Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Salivary Gland Neoplasms × bicalutamide × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Salivary Gland Neoplasms 1

Interventions

Immunohistochemistry 5 Polymerase Chain Reaction 3 Gene Expression Profiling 3 Biopsy 3 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Observation 2 Mass Spectrometry 2 Immunoenzyme Techniques 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 pyrotinib 1 bicalutamide 1 X-Ray Therapy 1 Tissue Array Analysis 1 Therapeutics 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Reverse Transcriptase Polymerase Chain Reaction 1 Quality of Life 1 Psychiatric Rehabilitation 1 Physical Therapy Modalities 1 Phlebotomy 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Oligonucleotide Array Sequence Analysis 1 Neoadjuvant Therapy 1 Molecular Diagnostic Techniques 1 Microarray Analysis 1 Mental Status and Dementia Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05087706 2021-10-21

MAPS

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡